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http://journal.chemistrycentral.com/content/6/1/61RESEARCH ARTICLE Open AccessGreen tea increases the survival yield of
Bifidobacteria in simulated gastrointestinal
environment and during refrigerated conditions
Dan C Vodnar and Carmen Socaciu*Abstract
Background: The well–known prebiotics are carbohydrates but their effects may not always be beneficial, as they can
also encourage the growth of non-probiotic bacteria such as Eubacterium biforme and Clostridium perfringens.
Therefore, new alternatives such as non-carbohydrate sources to stimulate the growth of probiotics are needed. The
aim of this work was to evaluate (I) the green tea polyphenols by HPLC-LC/MS and (II) the protective effect of green
tea extract on viability and stability of B. infantis ATCC 15697 and B. breve ATCC 15700 microencapsulated in chitosan
coated alginate microcapsules during exposure to simulated gastrointestinal conditions and refrigerated storage.
Results: The major compound identified by HPLC-LC/MS in green tea was epigallocatechin gallate followed by
caffeine and epigallocatechin. The survival yield of probiotic bacteria in microcapsules with 10% GT during storage at 4°
C, demonstrated significantly (P< 0.05) higher number of survival bacteria. Microencapsulated B.infantis and B. breve
with 5% and 10% GT showed a significantly (P< 0.05) improved survival under simulated gastric conditions (pH 2.0,
2 h) and bile solution (3%, 2 h) when they were compared with microencapsulation without GT addition.
Conclusions: The results of this study suggest that green tea coencapsulated with B. infantis or B. breve exert a
protective effect of bacteria during exposure to gastrointestinal conditions and refrigerated storage. For a health
perspective, the results confirm the growing interest probiotic bacteria and the perceived benefit of increasing their
numbers in the gastrointestinal tract by microencapsulation.
Keywords: Green Tea, B. Infantis, B. Breve, Microencapsulation, Gastrointestinal conditions, PolyphenolsBackground
The active delivery of probiotic cells in microencapsu-
lated form has received reasonable attention during the
last 10 years, since it can reduce losses of sensitive bac-
teria induced by detrimental external factors during stor-
age and digestion [1]. Several reviews [2] summarized
the potential of microencapsulation to improve probiotic
survival during storage or gastrointestinal transit. Algin-
ate is the most widely used matrix for microencapsula-
tion, but its use is limited due to low stability in acidic
conditions [3,4]. Therefore coating of alginate with chit-
osan improved the stability of alginate beads and thus
improved the viability of the encapsulated probiotic bac-
teria, as previously shown by Krasaekoopt et al. [5].* Correspondence: socaciucarmen@gmail.com
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distribution, and reproduction in any mediumBifidobacteria selectively colonize the intestinal tract of
breastfed infants and are also relevant colonic bacteria in
adults [6]. The strains commonly regarded as human pro-
biotics belong to the species Bifidobacterium bifidum,
B. breve, B. infantis, B longum, B. lactis and B. animalis,
which are included in functional dairy products [6]. Bifi-
dobacterium longum, B. adolescentis, and B. catenulatum
are most commonly found in adult faecal samples while
B. infantis and B. breve are predominantly present in
infant’s faeces [7]. Though, B. infantis and B. breve are also
found in certain numbers in adults [8]. Strains of B. infantis
are considered particularly beneficial due to its enhanced
ability to inhibit gastrointestinal pathogens through direct
anti-microbial action and to attenuate colitis [9].
Prebiotics are non-digestible carbohydrates that bene-
ficially affect the host after ingestion as they are available
as a selective energy source for probiotic Lactobacilli
and Bifidobacteria, stimulating their growth and activityMed Central Ltd. This is an Open Access article distributed under the terms of
ttp://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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http://journal.chemistrycentral.com/content/6/1/61in the colon [10]. The effects of carbohydrate-type pre-
biotics may not always be beneficial, as they can also en-
courage the growth of non-probiotic bacteria. Bello et al.
[11] demonstrated that the use of fructo-oligosacharides
(FOS) resulted in enhanced growth of Eubacterium
biforme and Clostridium perfringens. Therefore, new
alternatives such as non-carbohydrate sources to stimu-
late the growth of probiotics are needed.
It is believed that the efficiency of probiotic health
benefits can be enhanced by coupling the application of
probiotics with a selective prebiotic growth substance,
thus favoring colonization of probiotics in the human
gut [12]. Hence, a combined application of pro- and pre-
biotics, a concept referred to as symbiotic, also emerged
in the field of probiotic microencapsulation.
Green tea (Camelia sinensis) is one of the most widely
consumed beverages in the world and has multiple
health benefits, such as anti-stress [13], anticancer [14],
antioxidant [15] and neuroprotective effects [16]. Green
tea active polyphenols include (−)-epigallocatechin-3-
gallate (EGCG), (−)-epigallocatechin (EGC), (−)-epicate-
chin-3-gallate (ECG), and (−)-epicatechin [17].
In the present study, we evaluated (I) the green tea
polyphenols by HPLC-MS and (II) the protective effect
of green tea extract on viability and stability of B. infan-
tis and B. breve microencapsulated in chitosan coated al-
ginate microcapsules during exposure to simulated
gastrointestinal conditions and refrigerated storage.
Results and discussion
HPLC-LC/MS characterization of green tea extract
Figure 1. shows a chromatogram of extracted green tea
while the Table 1 lists the retention times, mass data,
concentration and the substance names for the num-

























R e ten t
Figure 1 HPLC chromatogram of phenolic compounds in green tea etea infusion were identified with reference compounds
and literature data on the basis of their HPLC retention
times and mass spectra.
The dominant peak 7 in Figure 1, was identified as caf-
feine by processing the same retention time and mass
spectrum, which had a [M+H]+ ion at m/z 195 Figure 2A.
Peak 3, 4, 6, 8, 9, 11 were all identified as catechins belong-
ing to the flavan-3-ol class of flavonoids. Peak 3 and 4 had
a [M+H]+ ion at m/z 307 and according to the mass frag-
ment ions were identified gallocatechin and epigallocate-
chin. Peak 6 was identified as catechin which had a
[M+H]+ ion at m/z 291. Peak 9 showed a mass spectrum
which corresponded with epigallocatechingalate Figure 2
C. Peak 11 had a [M+H]+ ion at m/z 443 (Figure 2B)
which clearly confirmed the catechingallate compound.
Peak 1 and 2 were identified as phenolic acids according
to the mass spectrum. Peak 1 produced the [M+H]+
ion at 335 and mass fragment ions at m/z 189 and 171,
which corresponded to quinic and gallic acid. Thus, peak 1
was identified as galloylquinic acid, peak 2 was confirmed
as gallic acid. As can be seen in Table 1, the major com-
pound in green tea extract was epigallocatechingalate
53.18 mg/ml followed by caffeine 19.16 mg/ml and epigal-
locatechin 7.13 mg/ml.
Microcapsules characteristics. Size, entrapment efficiency
and viability
Table 2. shows results for diameters and encapsulation
yields of chitosan-coated alginate microcapsules containing
B. infantis or B. breve with or without addition of green tea.
The mean diameters of all types of microcapsules were be-
tween 318.23 and 344.19 μm. EY was higher for microcap-
sules with B. infantis as compared to all trials and low
differences between microcapsules with B. breve, B+ 5%GT,




ion  T im e  (m in )
xtract. Peak numbers correspond to Table1.
Table 1 Retention time, mass spectral data and concentration of phenolic compounds from green tea extract
Peak nr. Rt (min) [M+H]
+ (m/z) Compound Concentration mg/ml
1 3.77 335 Galloylquinic acid 6.18
2 4.17 171 Galic acid 0.59
3 6.66 307 Gallocatechin 4.5
4 9.13 307 Epigallocatechin 7.13
5 10.60 340 Dicafeic acid 0.32
6 11.09 291 Catechin 1.59
7 12.08 195 Caffeine 19.16
8 16.02 291 Epicatechin 3.34
9 17.26 459 Epigallocatechingalate 53.18
10 26.42 304 Ellagic acid 0.82
11 27.91 443 Catechingallate 3.29
12 29.45 466 Quercetin glucoside 0.35
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http://journal.chemistrycentral.com/content/6/1/61probiotic bacteria with quercetin (prebiotic) has poor en-
capsulation efficiency and low viability of the cells in quer-
cetin beads due to interaction of flavonoid with probiotic
[18,19]. Our results showed difference between viability of
bacteria in beads, increasing the viability of bacteria
from microcapsules without GT (B: 9.24 log CFU/mL, I:
9.34 log CFU/mL) to microcapsules with 5% GT (B: 9.39
log CFU/mL, I: 9.28 log CFU/mL) and 10% GT (B: 9.43 log
CFU/mL, I: 9.36 log CFU/mL), respectively.
Survival of free and microencapsulated cells in SGJ
Several studies have shown that only microencapsulated
probiotics were able to maintain viability in gastrointestinal
conditions [20]. Immobilization of bacteria in alginate
beads has previously been tested for improving the viability
of probiotic bacteria in simulated gastric conditions [21].
Sultana et al. [4] found the encapsulation of bacteria in al-



























Figure 2 Mass spectra of Caffeine 195 (m/z) (A), Catechingallate 443 (high acidity. On the other hand, some authors reported the
effect of alginate encapsulation on survival of lactic bacteria
in simulated gastrointestinal conditions [4,18], there is no
uniformity in the reported results.
Viability of immobilized and free cells of probiotic bac-
teria with and without addition of GT, in simulated gastric
juice was evaluated and the results were shown in Figure 3.
Encapsulation in chitosan-coated alginate beads signifi-
cantly (P< 0.05) protected survival of B. infantis and
B. breve. Microencapsulated B. infantis and B. breve with
or without GT were resistant to simulated gastric condi-
tions. In capsules without addition of GT, the survival rate
of bacteria was lower comparing with the capsules con-
taining 5% and 10% GT addition. Thus, the survivability
rate increased proportionally with the concentration of
GT addition. A significant differences (P< 0.05) was noted
between cell survival of B. breve with addition of 10% GT





































































m/z) (B), Epigallocatechingalate 459 (m/z) (C).
Table 2 Size, encapsulation yield and viability of bacteria in different beads containing green tea
Beads Type Beads Size (μm; n=50) Encapsulation yield (%; n= 15) Viability (log CFU/mL, n= 4)
I + 5% GT 344.19 ± 1 37.14 ± 0.4 9.28 ± 0.3
I + 10% GT 339.1.6 ± 1 35.33 ± 0.7 9.36 ± 0.2
B + 5% GT 329.36 ± 1 37.18 ± 0.4 9.39 ± 0.3
B +10% GT 331.25 ± 1 36.15 ± 0.7 9.43 ± 0.4
I 325.14 ± 0.5 38.24 ±0.5 9.34 ± 0.3
B 321.08 ± 0.9 37.24 ±0.8 9.24 ± 0.4
10% GT 318.23 ± 1
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http://journal.chemistrycentral.com/content/6/1/615% and 10% GT extract increased the number of survival
cells after 120 min of exposure to SGJ in comparation
with microcapsules without GT addition. Thus, green tea
exerts the stimulative effect on B. infantis and B. breve. It
is estimated that 107 CFU/mL of live probiotic cells are
needed to confer health benefits to the consumer [22].
However, there was a rapid loss of free probiotic bacteria
in SGJ, initial number of 9 log CFU/mL for free strains
decreased to less than 2.6 log CFU/mL after exposure
of 2 h.
Some reports have indicated differences among strains
of probiotic bacteria with respect to their survival in acid
environment [23]. Krasaekoopt et al. [5] found that en-
capsulation with alginate coated with chitosan was the
best treatment to protect studied bacteria for all condi-
tions tested. Molan et al. [24] demonstrated the prebiotic
effect of green tea containing selenium promoting the
growth of Lactobacillus ssp. and Bifidobacterium ssp.
under in vitro conditions. The mechanism by which tea
extract increased the growth of probiotic bacteria remain






























Figure 3 Survival of free and encapsulated B. infantis (I) and B. breve
during exposure to simulated gastric juice at 37°C for 120 min. The er
replicated experiments. Means with different letter in a column are significeffect was presented by Molan et al. [24] consisting on
the ability of polyphenols in green tea, to act as antioxi-
dant and antiradical agents, to modulate the oxidative
stress in the medium generated by the metabolic activ-
ities and consequently provide a better environment for
the growth and multiplication of strains.
Survival of microencapsulated probiotic bacteria in SIJ
Chitosan-coated alginate beads were the most effective
in protecting probiotic bacteria from bile salt [19]. The
chitosan coating provides protection in bile salt solution
because an ion exchange reaction takes place when the
beads absorb bile salt [25]. Krasaekoopt et al. [5] found
that microencapsulation with alginate coated with chito-
san was the best treatment to protect studied probiotic
bacteria for all condition tested.
Viability of immobilized of free cells and B. infantis
and B. breve with and without addition of (5%, 10%) GT
in simulated intestinal juice was evaluated and the
results were shown in Table 3. In the case of free B.









(B) with and without addition of 5% and 10% green tea (GT)
ror bars indicate standard deviations from the mean values of three
antly different (p< 0.05). For abbreviations see Table 4.
Table 3 Number of survival cells (log CFU/mL) during
sequential incubation (37°C) in simulated intestinal juice
Beads Type Simulated Intestinal Juice (SIJ)
0 min 60 min 90 min 120 min
I +5% GT 8.85 ± 0.3 8.75 ± 0.4 8.20 ± 0.5 7.89 ± 0.6
I +10% GT 8.99 ± 0.1 8.79 ± 0.1 8.48 ± 0.6 8.23 ± 0.4
B + 5%GT 8.98 ± 0.5 8.64 ± 0.6 8.44 ± 0.1 7.46 ± 0.8
B + 10%GT 8.87 ± 0.7 8.75 ± 0.9 8.68 ± 0.5 8.19 ± 0.5
B 9.04 ± 0.3 8.72 ± 0.5 8.03 ± 0.4 7.68 ± 0.7
I 9.11 ± 0.6 8.84 ± 0.1 8.15 ± 0.7 7.88 ± 0.6
Free B. breve 9.24 ± 0.2 6.81 ± 0.8 4.75 ± 0.5 2.45 ± 0.4
Free B. infantis 9.34 ± 0.1 6.93 ± 0.1 4.56 ± 0.2 2.89 ± 0.3
Vodnar and Socaciu Chemistry Central Journal 2012, 6:61 Page 5 of 8
http://journal.chemistrycentral.com/content/6/1/619.24 log CFU/mL and 9.34 log CFU/mL was reduced to
4.56 log CFU/mL and 4.75 log CFU/mL after 90 min
and the average viable number was further reduced to
2.89 log CFU/mL and 2.45 log CFU/mL after 120 min.
The survival percentage of microencapsulated bacteria
after exposure to SIJ for 120 min was highest in trials
with 10% GT being 91.54% and 92.33% from the initial
cell population found in encapsulated I +GT 10% and
B+GT 10%. 10% GT exert a positive effect on surviv-
ability of probiotic bacteria after 120 min of SIJ expos-
ure, enhancing the number of B. infantis with 5.05% and
B. breve with 7.38% when was coencapsulated with
them.
Resistance to refrigerated storage
Experiments were performed in order to evaluate the effi-






























Figure 4 Survival of B. infantis (I) and B. breve (B) with and without ad
(4 ± 1°C). Means (n = 3) ± SD. Means with different letter in a column are siprobiotics viability under refrigeration. The results of the
B. infantis and B. breve survival of with and without
addition of green tea extract under 30 days of incubation
at 4± 1°C are presented in Figure 4. Results showed that
at the end of this time, the immobilized cells in 10% GT
had the lowest loss of viability (0.94 log CFU/mL for B.
infantis and 0.82 log CFU/mL for B. brevis). The viability
of microencapsulated cells showed different stability be-
tween microcapsules with or without GT in the same stor-
age conditions. After 30 days, the survival of free B.
infantis and B. breve decreased from 3.5 x 109 to 3.4 x
107 CFU/mL and from 2.4 x 109 to 3.1 x 107 CFU/mL re-
spectively. The number of microencapsulated bacteria
with 10%, 5% GT was significantly higher (P< 0.05) than
microencapsulated bacteria without GT and free bacteria.
The rate of decrease was significantly different (P< 0.05)
between the microencapsulated with and without 10%
GT. Koo et al. [26] reported that probiotic bacteria loaded
in chitosan-coated alginate microcapsules showed higher
storage stability than free cell culture. We also observed a
similar effect in our study. One of the properties for a
given microorganism to be considered probiotic is its cap-
acity to survive storage as a formulated product. In gen-
eral, fermented products containing added probiotics
should be stored under refrigeration at 4°C. Our results,
suggest that immobilization of B. infantis and B. breve
with GT improve viability of probiotics during refriger-
ation storage
Conclusions
The results of this study clearly show that the major com-








dition of 5% and 10% green tea (GT) under refrigerated storage
gnificantly different (p< 0.05). For abbreviations see Table 4.
Table 4 Chitosan coated alginate beads with bacteria and
green tea
Trials Abbreviation
Beads with 5% Green Tea and B. infantis I +5% GT
Beads with 10% Green Tea and B. infantis I +10% GT
Beads with 5% Green Tea and B. breve B + 5% GT
Beads with 10% Green Tea and B. breve B + 10% GT
Beads with B. infantis I
Beads with B. breve B
Beads with 10% Green Tea 10%GT
The trials abbreviations are presented.
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http://journal.chemistrycentral.com/content/6/1/61by caffeine and epigallocatechin. 5%, 10% green tea coen-
capsulated in chitosan coated alginate beads, exert a
stimulative effect on B. infantis and B. breve. The micro-
encapsulation with 10% green tea (w/v) was more effective
in maintaining the bacteria stability and increased their
viability by storage at refrigeration temperature during
30 days. Also, green tea, significantly improved the bacter-
ial survival in simulated gastrointestinal environment, and
allows viable cells reach a beneficial level of probiotic. In
conclusions, green tea microcapsules with probiotic bac-
teria offers an effective way to increase the life-spam and
survivability in simulated gastrointestinal juices and main-
taining their survival during refrigerated storage. For a
health perspective, the results confirm the growing inter-
est in probiotic bacteria and the perceived benefit of in-
creasing their numbers in the gastrointestinal tract.
Methods
Preparation of tea extracts
Green tea (GT) was purchased from an online shop and is
presently available on the market. GT is originally from
China and the content of total polyphenols was reported
on the prospectus as 40%. The aqueous extracts were
made by adding 10 ml water (100°C) to 0.1 g or 0.2 g tea
leaves and brewing for 10 min with stirring and removing
solid matter by filtration.
Chemical characterization of green tea extract
The chromatographic system used was an HPLC-DAD
Agillent Technology (USA) series 1200 coupled with LC/
MS single-quadrupole mass spectrometer equipped with a
pneumatically assisted ESI source. The column was a
Eclipse XDB-C18, 150x4,6 mm, (5μm) from Agillent
(USA). The phenols were separated with a mobile phase
consisting of 1% (v/v) formic acid (mobile phase A) and
acetonitril (mobile phase B). A gradient run was started at
90% gradient A, decreasing in 30 min to 75%, further de-
creasing to 10% in 15 min and then back to 90% in 10 min.
Total run for each sample was 55 min. The flow rate was
0.5 ml/min. The diode array detector was set to acquisition
range of 200-600 nm. The HPLC effluent entered the
mass spectrometer through an electrospray capillary set at
3.0 kV at a source block temperature of 100°C and a deso-
lvation gas temperature of 350°C. Nitrogen was used at
flow rate of approximately 8 L/min. The mass spectra be-
tween m/z 100 and 600, were obtained at a scan speed of
250m/z.
Bacterial strains and culture condition
Bifidobacterium infantis ATCC 15697 and Bifidobacter-
ium breve ATCC 15700 were purchased in lyophilized
form Bioaqua, Romania. Bacteria were routinely grown
in MRS broth. Shortly, freeze-dried cells were inoculated
into 5 mL MRS (de Man, Rogosa, Sharpe) broth (Merck,Germany) and incubated at 37°C, for 24 h under anaer-
obic conditions, and afterwards sub-cultured into 95 mL
broth and incubated under the same conditions. The
cells were harvested by centrifugation at 3000 g for
5 min at 4°C washed twice with sterile 0.9% (w/v) so-
dium chloride solution and resuspended in 2.5 mL of so-
dium chloride solution 0.5% (w/v).
Microencapsulation and coating procedures
The method described by Sheu and Marshall [27] was
adopted for microencapsulation of bacteria strains. The
water-GT extract was mixed with 20 g/L of sodium alginate
powder (Promova Biopolymer Norway), and sterilized. The
cell suspension (2.1x109 CFU/mL)were used as free cells or
were aseptically mixed with 10 mL of 2% (w/v) alginate so-
lution containing or not 5% or 10% Green Tea (GT) ex-
tract, (Table 4) and were applied to the immobilization
system. The chitosan and sodium alginate solutions were
prepared according to Krasaekoopt et al. [28]. Briefly, the
beads were immersed in 100 mL of chitosan solution 0.4%
(w/v) and shaken at 100 rpm, 37° C for 40 min on an or-
bital shaker for coating. The chitosan- coated alginate
beads were collected by centrifugation (500 rpm, 10 min
at 4° C). The microcapsules were washed twice with 0.9%
(w/v) sodium chloride solution and ressuspended in 50 mL
of 0.5% (w/v) sodium chloride solution.
Survival assay and numeration of microencapsulated
bacteria
Entrapped bacteria were released by homogenizing 1 mL
of bead suspension in 9 mL of sodium citrate 0.1 M for
10 min, stirred diluted and poured in MRS agar plate.
The plates were incubated 2 days at 37°C, and the
released bacteria enumerated as CFU/mL. The encapsu-
lation yield (EY), which is a combined measurement of
the efficacy of entrapment and survival of viable cells
during the microencapsulation procedure, was calculated
as: EY= (N/No) x 100. N is the number of free living
cells released from the microcapsules, and No is the
number of free cells added to the biopolymer mix during
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formation of microcapsules were measured with a light
microscope (Axio, Observer A1, Zeiss). The data analysis
was performed using software UTHSCSA (University of
Texas Health Science Center, San Antonio) Image Tool
software (University of Texas Health Science Center, San
Antonio, TX, USA).
Resistance to gastrointestinal conditions
Simulated gastric juice (SGJ) consisted of 9 g/L of sodium
chloride containing 3 g/L of pepsin with pH adjusted to
2.0 with hydrochloric acid. 1 mL of cell suspension of
B. infantis or B. breve were mixed in 9 mL SGJ and incu-
bated for 30, 60, 90 and 120 min at 37°C with constant
agitation of 50 rpm.
Simulated intestinal juice (SIJ) was prepared by dis-
solving bile salts (Oxoid, Basingstoke, UK) in intestinal
solution (6.5 g/L NaCl, 0.835 g/L KCl, 0.22 g/L CaCl2
and 1.386 g/L NaHNO3 ) pH 7.5 to final concentrations
of 3.0 g/L (Chavarri et al., 2010). Triplicate samples were
mixed, incubated at 37°C and sampled 30, 60, 90,
120 min after addition of cell suspension. Surviving bac-
teria were numerated by pour plated counts in MRS agar
incubated at 37°C.
Resistance to refrigerated storage
The viability of probiotic bacteria under refrigeration
was evaluated by incubating 1 mL (approximatively 3.8 x
10 9 cells/mL) of free and immobilized cell suspension in
9 mL of 5% (w/v) sterile sodium chloride solution. Ali-
quots of 1 mL were taken every day for 30 days to deter-
mine the total number of viable cells.
Statistical analysis
Results for 3 individual experiments were used to calculate
the mean of cell counts. Analysis of variance (ANOVA)
and Duncan’s multiple range tests were performed to
analyze the results. Significance of difference was defined
at the 5% level (P< 0.05). All statistical analysis was car-
ried out using Graph Pad Version 4.0 (Graph Pad Soft-
ware Inc; San Diego, CA, USA).
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